Cargando…

Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation

SIMPLE SUMMARY: Anti-PD-1/PD-L1 and anti-CTLA-4-based immune checkpoint blockade (ICB) immunotherapy have recently emerged as a breakthrough in human cancer treatment. Durable efficacy has been achieved in many types of human cancers. However, not all human cancers respond to current ICB immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moorman, Hannah R., Poschel, Dakota, Klement, John D., Lu, Chunwan, Redd, Priscilla S., Liu, Kebin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698217/ https://www.ncbi.nlm.nih.gov/pubmed/33203146 http://dx.doi.org/10.3390/cancers12113379

Ejemplares similares

Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression
por: Klement, John D., et al.
Publicado: (2021)

WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape
por: Lu, Chunwan, et al.
Publicado: (2021)

Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
por: Lu, Chunwan, et al.
Publicado: (2019)

IRF8: Mechanism of Action and Health Implications
por: Moorman, Hannah R., et al.
Publicado: (2022)

Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo
por: Merting, Alyssa D., et al.
Publicado: (2022)

IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T Lymphocytes
por: Poschel, Dakota B., et al.
Publicado: (2023)

p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy
por: Lu, Chunwan, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis
por: Ibrahim, Mohammed L., et al.
Publicado: (2018)

Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes
por: Coe, Genevieve L., et al.
Publicado: (2016)

G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes
por: Lu, Chunwan, et al.
Publicado: (2022)

CD133(+)CD24(lo) defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype
por: Paschall, Amy V., et al.
Publicado: (2016)

Osteopontin at the Crossroads of Inflammation and Tumor Progression
por: Castello, Luigi Mario, et al.
Publicado: (2017)

5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL(+) Cytotoxic T Lymphocyte Cytotoxicity
por: Yang, Yingcui, et al.
Publicado: (2023)

Lymphatics in Tumor Progression and Immunomodulation
por: Li, Claire Y., et al.
Publicado: (2022)

The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages
por: Tan, Yuying, et al.
Publicado: (2022)

The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription
por: Simon, Priscilla S., et al.
Publicado: (2015)

Role of osteopontin in tumour progression
por: Rittling, S R, et al.
Publicado: (2004)

Down-regulation of osteopontin attenuates breast tumour progression in vivo
por: Chakraborty, Goutam, et al.
Publicado: (2008)

Osteopontin facilitates tumor metastasis by regulating epithelial–mesenchymal plasticity
por: Jia, Rongjie, et al.
Publicado: (2016)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications
por: Amilca-Seba, Katyana, et al.
Publicado: (2021)

Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer
por: Plundrich, Dorothea, et al.
Publicado: (2022)

NF-κB functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression
por: Simon, Priscilla S., et al.
Publicado: (2016)

The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression
por: Lin, Chang-Ni, et al.
Publicado: (2015)

H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth
por: Lu, Chunwan, et al.
Publicado: (2022)

The role of osteopontin in the progression of solid organ tumour
por: Zhao, Hailin, et al.
Publicado: (2018)

Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis
por: Shao, Zhuce, et al.
Publicado: (2023)

Osteopontin regulates human glioma cell invasiveness and tumor growth in mice
por: Jan, Hsun-Jin, et al.
Publicado: (2010)

Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer
por: Sun, Ming, et al.
Publicado: (2020)

Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells
por: Lu, Chunwan, et al.
Publicado: (2018)

Functional Characterization of Stromal Osteopontin in Melanoma Progression and Metastasis
por: Kumar, Santosh, et al.
Publicado: (2013)

Osteopontin (OPN) alleviates the progression of osteoarthritis by promoting the anabolism of chondrocytes
por: Luo, Wei, et al.
Publicado: (2022)

Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells
por: Saleh, S., et al.
Publicado: (2016)

Osteopontin binds ICOSL promoting tumor metastasis
por: Raineri, Davide, et al.
Publicado: (2020)

Osteopontin as a Tumor Marker in Ovarian Cancer
por: Rani, Shikha, et al.
Publicado: (2022)

Immunomodulation in the Treatment of Periodontitis: Progress and Perspectives
por: Yang, Bo, et al.
Publicado: (2021)

Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs
por: Tomei, Sara, et al.
Publicado: (2021)

The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression
por: Comi, Cristoforo, et al.
Publicado: (2012)

Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors
por: Hsu, Kai-Hsi, et al.
Publicado: (2014)

Gut microbiota-mediated immunomodulation in tumor
por: Liu, Xinyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g5g57o39kp0jh22eta7702ok6t